Icure Pharmaceutical Incorporation (KOSDAQ:175250)

KOSDAQ:175250 Revenue

In the year 2024, Icure Pharmaceutical Incorporation had annual revenue of 69.21B KRW with 21.83% growth. Icure Pharmaceutical Incorporation had revenue of 20.70B in the quarter ending December 31, 2024, with 71.02% growth.

• Revenue: 69.21B
• Revenue Growth: +21.83%
• P/S Ratio: 0.87
• Revenue / Employee: 345.87M
• Employees: 218
• Market Cap: 65.88B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	69.21B	12.40B	21.83%
Dec 31, 2023	56.81B	-2.56B	-4.31%
Dec 31, 2022	59.37B	-4.92B	-7.65%
Dec 31, 2021	64.28B	-25.86B	-28.69%
Dec 31, 2020	90.14B	29.22B	47.97%